MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC
- Type
- Correction
- Notice date
- 3/11/2019 0:00
- Journal
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.biopha.2019.108755
- Original paper DOI
- 10.1016/j.biopha.2018.11.065